Jan Schlender - Bayer AG, Clin Pharmacometr Res & Dev Pharmaceut

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 11 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Pharmacometrics (pmx) approach to support pediatric dosing for the pan-pi3k inhibitor copanlisib in children and adolescents with relapsed/refractory solid tumors

P. Morcos,J. Schlender,R. Burghaus, J. Moss, A. Lloyd, F. Huang,B. Childs,M. Macy,J. Reid,J. Chung,D. Garmann

CLINICAL PHARMACOLOGY & THERAPEUTICS (2023): S68-S68

引用0浏览0引用

Physiologically Based Pharmacokinetic (PBPK) Modelling of Oral Drug Absorption in Older Adults - an AGePOP Review

Cleo Demeester, Donnia Robins,Angela Elma Edwina,Jos Tournoy,Patrick Augustijns,Ibrahim Ince,Andreas Lehmann,Maria Vertzoni,Jan Frederik Schlender

European journal of pharmaceutical sciences official journal of the European Federation for Pharmaceutical Sciences (2023): 106496-106496

引用2浏览0WOS引用

Model‐informed Approach to Support Pediatric Dosing for the Pan‐pi3k Inhibitor Copanlisib in Children and Adolescents with Relapsed/refractory Solid Tumors

Peter N. Morcos,Jan Schlender,Rolf Burghaus,Jonathan Moss, Adam Lloyd,Barrett H. Childs,Margaret E. Macy, Joel M. Reid,John Chung,Dirk Garmann

CTS-CLINICAL AND TRANSLATIONAL SCIENCEno. 7 (2023): 1197-1209

引用0浏览0WOS引用

The Novel Soluble Guanylyl Cyclase (sgc) Activator Runcaciguat Induced Renal Vasodilation and Reduced Kidney Damage in a Rat CKD Model

Agnes M. Benardeau,Michael G. Hahn,Michael Gerisch,Michaela Meyer, Dzianis Menshykau,Terence Hetzel,Jan Schlender,Elke Hartmann,Tibor Schomber,Andreas Patzak,Frank Schweda,Jan R. Kraehling,Peter Sandner,Frank Eitner

Journal of the American Society of Nephrologyno. 10S (2020): 232-232

引用0浏览0引用

Predictive Pediatric Modeling and Simulation Using Ontogeny Information

Ibrahim Ince,Juri Solodenko,Sebastian Frechen,André Dallmann,Christoph Niederalt,Jan Schlender,Rolf Burghaus,Jörg Lippert,Stefan Willmann

JOURNAL OF CLINICAL PHARMACOLOGY（2019）

引用27浏览0WOS引用

PHYSIOLOGICALLY-BASED PHARMACOKINETIC AND CLINICAL STUDY TO ASSESS EFFECTS OF CYP3A INDUCTION AND INHIBITION ON COPANLISIB PK IN CANCER PATIENTS

J. -F. Schlender,J. Grevel, S. Frechen, C. Diedrich,R. Burghaus,A. Spreafico,M. Sawyer,L. L. Siu,F. Huang,S. Reschke, C. Xia, Z. Yan,I. Genvresse,G. Cisternas,A. Kelly,S. Reif,C. Granvil

CLINICAL PHARMACOLOGY & THERAPEUTICSno. SUPnan (2019): S70-S70

引用1浏览0引用

ASSESSMENT OF MIDAZOLAM PHARMACOKINETICS IN HEPATICALLY IMPAIRED POPULATIONS BY PBPK

M. Block,A. Schneider,K. Coboeken,J. Schlender

CLINICAL PHARMACOLOGY & THERAPEUTICS（2018）

引用0浏览0引用

Translational Learning from Clinical Studies Predicts Drug Pharmacokinetics Across Patient Populations

Markus Krauss,Ute Hofmann,Clemens Schafmayer,Svitlana Igel,Jan Schlender,Christian Mueller,Mario Brosch,Witigo von Schoenfels,Wiebke Erhart,Andreas Schuppert,Michael Block,Elke Schaeffeler, Gabriele Boehmer,Linus Goerlitz,Jan Hoecker,Joerg Lippert,Reinhold Kerb,Jochen Hampe,Lars Kuepfer,Matthias Schwab

npj systems biology and applicationsno. 1 (2017)

引用12浏览0WOSNATURE引用

The Personalization Of Drug Therapy For Elderly Patients

Jan F. Schlender,Adam G. Golden,Tanay S. Samant,Chakradhar V. Lagishetty,Stephan Schmidt

DEVELOPING DRUG PRODUCTS IN AN AGING SOCIETY: FROM CONCEPT TO PRESCRIBING (2016): 589-611

引用1浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn